Navigation Links
Quest Diagnostics and Genomic Vision Form Strategic Collaboration to Develop Genome-based Laboratory Tests
Date:7/14/2011

MADISON, N.J. and PARIS, July 14, 2011 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, and Genomic Vision, a biotechnology company dedicated to the development of molecular diagnostics, today announced a multi-year exclusive collaboration involving Genomic Vision's proprietary molecular combing genomic-analysis technology.  

Under terms of the agreement, Quest Diagnostics has exclusive rights to develop and offer clinical- and research-use laboratory testing services based on Genomic Vision's molecular combing (also known as DNA combing) technique in the United States, India and Mexico. Genomic Vision will retain rights to market new testing services that emerge from the collaboration's research and development in Europe (with the exception of the United Kingdom), the Middle East and Africa. Quest Diagnostics has also made an equity investment for an undisclosed sum in Genomic Vision. Additional terms were not disclosed.

"Genomic Vision's DNA combing technology is a potential game changer in genomic analysis," said Jay G. Wohlgemuth, M.D., vice president, science and innovation, Quest Diagnostics. "Similar to how microarrays introduced an entirely new concept to analyze genetic alterations, DNA combing, by facilitating analysis of single DNA molecules, could radically improve our understanding of disease-causing mutations and, in turn, clinical testing and drug development."

DNA combing is an analytical technique that involves stretching coils of DNA into straight chains to facilitate direct high-resolution analysis of targeted areas of the human genome. Developed from research at the Pasteur Institute, the technique detects genetic mutations, most notably large scale gene rearrangements (in a range of one thousand to over a million DNA base pairs in length), which&#
'/>"/>

SOURCE Quest Diagnostics
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Clinical Genomics Extends Strategic Alliance for Colorectal Cancer Testing Development with Quest Diagnostics
2. GEN point of view article questions reported costs of drug R&D
3. Questcor Pharmaceuticals to Present at the Jefferies Global Healthcare Conference on June 9, 2011
4. FDA Requests Input on Development of User Fee Program for Biosimilar and Interchangeable Biological Products
5. GenomeQuest to Lead Biomarker World Congress Panel on Applying Whole Genome Sequencing to Developing Companion Diagnostics
6. New York State Approves the Quest Diagnostics ColoVantage™ Colorectal Cancer Blood Test
7. After the ABRF Conference: Gene Codes Flooded with Requests for Early Access to NextGen Software Tools
8. MDAs Augies Quest Expands Testing of Potential ALS Therapeutics With New $2 Million Grant to ALS TDI
9. Quest Diagnostics to Acquire Athena Diagnostics, Establishing Leading Position in Rapidly Growing Neurology Testing Market
10. Questcor Pharmaceuticals to Be Added to S&P SmallCap 600 Index
11. Quest Diagnostics® Care360™ EHR Receives ONC-ATCB 2011/2012 Certification
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2014)... 2014 Deep Research Report ... professional and in-depth research report on the ... Seaweed Fertilizer information, including Seaweed Fertilizer definition, ... well as industry overview. This research covers ... as well as global industry analysis covering ...
(Date:8/21/2014)... N.Y. (PRWEB) August 21, 2014 The ... the first private college in the Mid-Hudson Region to ... will now begin accepting applications from qualified “high-technology” businesses ... “We are very pleased to have been selected for ... Governor Cuomo’s transformative initiative to stimulate economic development in ...
(Date:8/21/2014)... Aug. 21, 2014  China Cord Blood Corporation (NYSE: ... to release financial results for the first quarter of ... market close in the US.  The ... ET on Friday, August 29, 2014 to discuss its ... Company,s recent developments, followed by a question and answer ...
(Date:8/21/2014)... (PRWEB) August 21, 2014 ... biopharmaceutical contract development and manufacturing organization (CMO) announced ... Pharmaceuticals, Inc., an oncology company focused on the ... cancer, to manufacture the anti-prostate specific membrane antigen ... product candidate. Under the agreement the antibody ...
Breaking Biology Technology:Internationals Seaweed Fertilizer Industry 2014 Development Trend Analysis in New Research Study at DeepResearchReports.com 2Internationals Seaweed Fertilizer Industry 2014 Development Trend Analysis in New Research Study at DeepResearchReports.com 3The College of New Rochelle Becomes First Private College in Mid-Hudson Region to Earn START-UP NY Designation 2The College of New Rochelle Becomes First Private College in Mid-Hudson Region to Earn START-UP NY Designation 3China Cord Blood Corporation to Report First Quarter of Fiscal 2015 Financial Results 2Gallus Enters Agreement with Progenics Pharmaceuticals, Inc. for Manufacture of Anti-PSMA Monoclonal Antibody 2Gallus Enters Agreement with Progenics Pharmaceuticals, Inc. for Manufacture of Anti-PSMA Monoclonal Antibody 3
... HARBIN, China, Sept. 15, 2011 /PRNewswire-Asia/ -- China Botanic Pharmaceutical ... "Company"), a developer, manufacturer and distributor of botanical products, bio-pharmaceuticals ... results for the three months ended July 31, 2011. ... Highlights and Recent Events ...
... New York Stem Cell Summit is releasing effective today an ... the general public understand more accurately the role that autologous ... today. Approximately 1 million patients have been treated ... United States. Harvesting stem cells from adult ...
... 2011 Aperion Biologics, Inc. announced that it has ... the Company,s clinical trial of its Z-Lig™ Anterior Cruciate ... injuries of the knee. The randomized multicenter study commenced ... to provide safety and performance data in the reconstruction ...
Cached Biology Technology:China Botanic Pharmaceutical Reports Third-Quarter Fiscal Year 2011 Results 2China Botanic Pharmaceutical Reports Third-Quarter Fiscal Year 2011 Results 3China Botanic Pharmaceutical Reports Third-Quarter Fiscal Year 2011 Results 4China Botanic Pharmaceutical Reports Third-Quarter Fiscal Year 2011 Results 5China Botanic Pharmaceutical Reports Third-Quarter Fiscal Year 2011 Results 6China Botanic Pharmaceutical Reports Third-Quarter Fiscal Year 2011 Results 7China Botanic Pharmaceutical Reports Third-Quarter Fiscal Year 2011 Results 8New York Stem Cell Summit Issues Adult Stem Cell Fact Sheet 2Aperion Biologics Reaches Midpoint of Enrollment in Z-Lig™ Anterior Cruciate Ligament Reconstruction Medical Device Performance Trial 2
(Date:8/21/2014)... that has implications for life in other extreme environments, ... system, LSU Associate Professor of Biological Sciences Brent Christner ... or NSF, this week published a paper confirming that ... 800 meters (2600 feet) beneath the surface of the ... that more than 400 subglacial lakes and numerous rivers ...
(Date:8/21/2014)... 2014 , WHERE: , San Diego Convention ... 92101 , WHAT: , Invited and platform ... research in human genetics. Examples of sessions include: ... rare genetic variants in health and disease, the ... sensitivity (Saturday, Oct. 18, 5:30-7:30 pm) , Crowdsourced ...
(Date:8/21/2014)... A team of researchers at Louisiana Tech ... using affordable, consumer-grade 3D printers and materials ... contain antibacterial and chemotherapeutic compounds for targeted ... doctoral students and research faculty from Louisiana ... collaborated to create filament extruders that can ...
Breaking Biology News(10 mins):800 meters beneath Antarctic ice sheet, subglacial lake holds viable microbial ecosystems 2800 meters beneath Antarctic ice sheet, subglacial lake holds viable microbial ecosystems 3800 meters beneath Antarctic ice sheet, subglacial lake holds viable microbial ecosystems 4American Society of Human Genetics 2014 Annual Meeting 2Louisiana Tech University researchers use 3D printers to create custom medical implants 2Louisiana Tech University researchers use 3D printers to create custom medical implants 3
... past several decades have led to heritable, genetic changes ... according to University of Oregon evolutionary geneticists. , Writing ... of SCIENCE, William E. Bradshaw, professor of biology, and ... populations have changed genetically in response to rapid climate ...
... years, scientists have identified a new genus of a living ... Science May 11 in the online Science Express. , ... of discovery' is by no means over," says William Stanley, ... The Field Museum, where the world's only specimen of this ...
... Kavli Institute of Nanoscience have discovered how to use ... on a chip. Based on this, they built a ... molecules individually. To demonstrate this, the Delft researchers sorted ... of the University of Florida has called the Delft ...
Cached Biology News:Recent, rapid climate change is driving evolution of animal species 2Scientists describe new African monkey genus ?first in 83 years 2Scientists describe new African monkey genus ?first in 83 years 3Biological motors sort molecules one by one on a chip 2
... an automated hybridization system for the processing ... the hybridization and post hybridization washing of ... instrument can process up to 12 slides ... multi-protocol software, enabling the user to run ...
... (GST) is commonly used as a fusion ... (1). The GSTTag sequence has been reported ... cases the solubility of its fusion partners. ... form, GSTTag fusion proteins can be purified ...
... the biological data hidden in your samples with ... allows you to create your own microarray designs ... your own pace and receive delivery of your ... is a secure, online array creation application tool ...
Acetylcholinesterase (human brain, AChE)...
Biology Products: